| Literature DB >> 16870280 |
Abstract
Anti-cardiac receptor autoantibodies have been studied intensively last 10 years. A growing evidence, both in vitro and in vivo and both clinical and experimental studies, have supported that these anti-cardiac receptor autoantibodies, mainly anti-beta1 adrenoceptor autoantibodies, play a very important pathophysiological role, at least partly, in the development of idiopathic dilated cardiomyopathy. This concise review article will only summarize studies done in rabbits with consideration of other articles in this focused issue.Entities:
Mesh:
Substances:
Year: 2006 PMID: 16870280 DOI: 10.1016/j.ijcard.2006.05.013
Source DB: PubMed Journal: Int J Cardiol ISSN: 0167-5273 Impact factor: 4.164